Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention
Chee Wai Fhu, Azhar Ali
Cancers (2021) Vol. 13, Iss. 7, pp. 1513-1513
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The gold complex auranofin: new perspectives for cancer therapy
Farah H. Abdalbari, Carlos M. Telleria
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 108
Ubiquitination and deubiquitination: Implications on cancer therapy
Gunjan Dagar, Rakesh Kumar, Kamlesh Yadav, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194979-194979
Closed Access | Times Cited: 35
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease
Haleh Barmaki, Alireza Nourazarian, Fatemeh Khaki‐Khatibi
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 24
Anticancer drugs: How to select small molecule combinations?
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 503-519
Closed Access | Times Cited: 14
Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis
Priyadarshana Ajithkumar, Sai Shyam Vasantharajan, Sharon Pattison, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 874-874
Open Access | Times Cited: 9
The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence
Bashar A. Alhasan, А. В. Морозов, Irina V. Guzhova, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189119-189119
Closed Access | Times Cited: 6
Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease
Lidong Wang, Xiaodan Sun, Jingni He, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
Roles of USP9X in cellular functions and tumorigenesis (Review)
Yimei Meng, Chaojin Hong, Sifu Yang, et al.
Oncology Letters (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 13
Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy
Yue Song, Qing‐Qing Dong, Yi-Ke Ni, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5739-5761
Open Access | Times Cited: 4
Differential expression and pathological implications of Linc01089 and Linc01578 in acute myeloid leukemia
Zahra Khosroabadi, Mohammadreza Sharifi, Mansour Salehi, et al.
Gene Reports (2025) Vol. 38, pp. 102129-102129
Closed Access
Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells
Farah H. Abdalbari, Elvis Martinez-Jaramillo, Benjamin N. Forgie, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5136-5136
Open Access | Times Cited: 10
Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells
Kexin Li, Xun Sun, Bai‐Yan Li, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5593-5593
Open Access | Times Cited: 17
Proteasome Inhibitors Decrease the Viability of Pulmonary Arterial Smooth Muscle Cells by Restoring Mitofusin-2 Expression under Hypoxic Conditions
I‐Chen Chen, Yi‐Ching Liu, Yen-Hsien Wu, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 873-873
Open Access | Times Cited: 11
The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma
Chunfeng Zhang, Yang Yang, Kun Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 11
Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System
Magdalena Staszczak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13309-13309
Open Access | Times Cited: 15
Design and synthesis of a fluorescent probe to develop a fluorescence polarization assay for the E3 ligase FEM1C
E. SEIPP, Rong Huang
Bioorganic & Medicinal Chemistry (2023) Vol. 90, pp. 117371-117371
Closed Access | Times Cited: 5
Role of heparanase 2 (Hpa2) in gastric cancer
Jingjing Liu, Ibrahim Knani, Miriam Gross-Cohen, et al.
Neoplasia (2021) Vol. 23, Iss. 9, pp. 966-978
Open Access | Times Cited: 12
UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma
Nuo Xu, Yi Cui, Shi Hong, et al.
Investigative Ophthalmology & Visual Science (2022) Vol. 63, Iss. 9, pp. 20-20
Open Access | Times Cited: 8
Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases
Kailing Pan, Junhao Fu, Wenxia Xu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 11
Targeted protein degradation: from small molecules to complex organelles—a Keystone Symposia report
Jennifer Cable, Eilika Weber‐Ban, Tim Clausen, et al.
Annals of the New York Academy of Sciences (2022) Vol. 1510, Iss. 1, pp. 79-99
Open Access | Times Cited: 8
Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 782-819
Closed Access | Times Cited: 4
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K
Cristian Prieto‐Garcia, Oliver Hartmann, Michaela Reissland, et al.
Molecular Oncology (2022) Vol. 16, Iss. 17, pp. 3082-3106
Open Access | Times Cited: 7
Auranofin induces lethality driven by reactive oxygen species in high-grade serous ovarian cancer cells
Farah H. Abdalbari, Elvis Martinez-Jaramillo, Benjamin N. Forgie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment
Yu Cao, Yutong Tu, Liping Fu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114211-114211
Closed Access | Times Cited: 5
High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
Hung‐Lung Ke, Yi‐Chen Lee, Wei‐Ming Li, et al.
Applied immunohistochemistry & molecular morphology (2022) Vol. 30, Iss. 4, pp. 304-310
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top